Clinical trial

Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer

NCT07675876

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-01

PhasePHASE1

Study timeline

Study start (estimated)2026-08-01Date precision: month

Registry last updated2026-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Locally Advanced Non-Small Cell Lung Cancerunresolved

Lung Adenocarcinomaunresolved

Interventions

Cromolyn SodiumDRUG · verified · RxNorm: cromolyn sodium

Sponsors & collaborators

Carcinex Inclead sponsor

Mapped research locations

DenverColorado, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07675876 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.